Financial Disclosures

Sinovac Biotech Ltd. received a Nasdaq notification for non-compliance with listing rules due to delayed financial filings. This adds to a previous delisting determination, with a hearing scheduled for January 8, 2026. The company is preparing to present its plan to rectify the issue and maintain its Nasdaq listing.